MedTrace Logo

Effect of Combined Use of Ivermectin and Colchicine in COVID-19 Patients

NCT05246072 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2022-04-07

No results posted yet for this study

Summary

The aim of this study will be to investigate the efficacy of use of combination of Ivermectin and colchicine on severity and outcome Of COVID 19 infection.

Conditions

Interventions

DRUG

Ivermectin + colchicine

In addition to the local standard of care for COVID 19 patients, the patient will receive Ivermectin + colchicine

DRUG

Colchicine

In addition to the local standard of care for COVID 19 patients, the patient will receive colchicine

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05246072 on ClinicalTrials.gov